Danielle Antalffy
Stock Analyst at UBS
(3.24)
# 2,402
Out of 4,417 analysts
603
Total ratings
49.9%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterated: Buy | $158 → $135 | $88.50 | +52.54% | 38 | Apr 20, 2026 | |
| BSX Boston Scientific | Rated: Buy | $120 → $105 | $44.95 | +133.59% | 42 | Mar 17, 2026 | |
| ISRG Intuitive Surgical | Rated: Hold | $570 → $550 | $402.18 | +36.75% | 10 | Mar 17, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $214 → $280 | $234.20 | +19.56% | 34 | Mar 17, 2026 | |
| SYK Stryker | Rated: Hold | $400 → $380 | $301.14 | +26.19% | 20 | Mar 17, 2026 | |
| SGHT Sight Sciences | Rated: Buy | $12 → $11 | $5.01 | +119.56% | 6 | Mar 6, 2026 | |
| TMCI Treace Medical Concepts | Maintained: Hold | $2.5 → $2.25 | $4.01 | -43.89% | 15 | Mar 2, 2026 | |
| PRCT PROCEPT BioRobotics | Maintained: Buy | $62 → $30 | $20.91 | +43.47% | 9 | Mar 2, 2026 | |
| RXST RxSight | Maintained: Hold | $8 → $9 | $4.63 | +94.59% | 11 | Feb 26, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $17 → $22 | $15.40 | +42.86% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $143.52 | +178.71% | 43 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $55 | $27.04 | +103.40% | 26 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.19 | +81.96% | 2 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 | $78.14 | +33.09% | 40 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $19 | $19.39 | -2.01% | 26 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $71.23 | +33.37% | 40 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $67 | $41.12 | +62.94% | 21 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $90 | $86.68 | +3.83% | 42 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $86 → $89 | $87.16 | +2.11% | 18 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $15.77 | +52.19% | 1 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $150 | $127.41 | +17.73% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $50 | $20.85 | +139.81% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $16 | $13.36 | +19.76% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $2.25 | $5.71 | n/a | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $103.19 | n/a | 10 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $15.16 | n/a | 11 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $2.34 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $6.27 | n/a | 5 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $275 | $141.61 | n/a | 6 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $55 | $4.02 | n/a | 10 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $39.13 | n/a | 14 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $44.57 | n/a | 6 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $5 | $0.477 | n/a | 14 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.37 | n/a | 20 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3 | $6.69 | n/a | 14 | Aug 9, 2021 |
Abbott Laboratories
Apr 20, 2026
Reiterated: Buy
Price Target: $158 → $135
Current: $88.50
Upside: +52.54%
Boston Scientific
Mar 17, 2026
Rated: Buy
Price Target: $120 → $105
Current: $44.95
Upside: +133.59%
Intuitive Surgical
Mar 17, 2026
Rated: Hold
Price Target: $570 → $550
Current: $402.18
Upside: +36.75%
Johnson & Johnson
Mar 17, 2026
Rated: Buy
Price Target: $214 → $280
Current: $234.20
Upside: +19.56%
Stryker
Mar 17, 2026
Rated: Hold
Price Target: $400 → $380
Current: $301.14
Upside: +26.19%
Sight Sciences
Mar 6, 2026
Rated: Buy
Price Target: $12 → $11
Current: $5.01
Upside: +119.56%
Treace Medical Concepts
Mar 2, 2026
Maintained: Hold
Price Target: $2.5 → $2.25
Current: $4.01
Upside: -43.89%
PROCEPT BioRobotics
Mar 2, 2026
Maintained: Buy
Price Target: $62 → $30
Current: $20.91
Upside: +43.47%
RxSight
Feb 26, 2026
Maintained: Hold
Price Target: $8 → $9
Current: $4.63
Upside: +94.59%
Tandem Diabetes Care
Feb 20, 2026
Maintained: Hold
Price Target: $17 → $22
Current: $15.40
Upside: +42.86%
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $143.52
Upside: +178.71%
Feb 18, 2026
Maintained: Buy
Price Target: $58 → $55
Current: $27.04
Upside: +103.40%
Feb 18, 2026
Reiterated: Buy
Price Target: $24
Current: $13.19
Upside: +81.96%
Feb 17, 2026
Maintained: Hold
Price Target: $104
Current: $78.14
Upside: +33.09%
Feb 16, 2026
Maintained: Hold
Price Target: $21 → $19
Current: $19.39
Upside: -2.01%
Feb 13, 2026
Reiterated: Buy
Price Target: $95
Current: $71.23
Upside: +33.37%
Feb 13, 2026
Maintained: Hold
Price Target: $89 → $67
Current: $41.12
Upside: +62.94%
Feb 12, 2026
Maintained: Hold
Price Target: $94 → $90
Current: $86.68
Upside: +3.83%
Feb 11, 2026
Maintained: Sell
Price Target: $86 → $89
Current: $87.16
Upside: +2.11%
Feb 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $15.77
Upside: +52.19%
Jan 28, 2026
Maintained: Buy
Price Target: $145 → $150
Current: $127.41
Upside: +17.73%
Jan 5, 2026
Maintained: Buy
Price Target: $57 → $50
Current: $20.85
Upside: +139.81%
Nov 6, 2025
Maintained: Hold
Price Target: $16 → $16
Current: $13.36
Upside: +19.76%
Mar 28, 2023
Initiated Coverage: Hold
Price Target: $2.25
Current: $5.71
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $100
Current: $103.19
Upside: n/a
May 12, 2022
Maintained: Buy
Price Target: $12
Current: $15.16
Upside: n/a
May 10, 2022
Maintained: Buy
Price Target: $13
Current: $2.34
Upside: n/a
May 9, 2022
Maintained: Buy
Price Target: $12
Current: $6.27
Upside: n/a
May 5, 2022
Rated: Hold
Price Target: $275
Current: $141.61
Upside: n/a
May 5, 2022
Rated: Buy
Price Target: $65 → $55
Current: $4.02
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $45
Current: $39.13
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $12 → $14
Current: $44.57
Upside: n/a
May 3, 2022
Rated: Buy
Price Target: $5
Current: $0.477
Upside: n/a
Jan 10, 2022
Maintained: Hold
Price Target: n/a
Current: $6.37
Upside: n/a
Aug 9, 2021
Reiterated: Hold
Price Target: $2 → $3
Current: $6.69
Upside: n/a